| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.807 | 0.005 | 0.807 | Tyrosine kinase inhibitor | 0.58 0.012 DBMET03429 0.58 0.012 DBMET03430 0.677 0.007 DBMET03431 0.735 0.005 DBMET03432 | ||
| 0.698 | 0.004 | 0.698 | Janus tyrosine kinase 3 inhibitor | 0.521 0.004 DBMET03429 0.521 0.004 DBMET03430 0.321 0.005 DBMET03431 0.581 0.004 DBMET03432 | ||
| 0.621 | 0.004 | 0.621 | Janus tyrosine kinase 2 inhibitor | 0.493 0.004 DBMET03429 0.493 0.004 DBMET03430 0.3 0.005 DBMET03431 0.546 0.004 DBMET03432 | ||
| 0.536 | 0.005 | 0.536 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.167 0.024 DBMET03429 0.167 0.024 DBMET03430 0.389 0.005 DBMET03431 0.323 0.008 DBMET03432 | ||
| 0.492 | 0.004 | 0.492 | Raf kinase inhibitor | 0.129 0.023 DBMET03429 0.129 0.023 DBMET03430 0.363 0.005 DBMET03431 0.276 0.008 DBMET03432 | ||
| 0.486 | 0.004 | 0.486 | Raf kinase B inhibitor | 0.134 0.016 DBMET03429 0.134 0.016 DBMET03430 0.36 0.005 DBMET03431 0.289 0.005 DBMET03432 | ||
| 0.475 | 0.008 | 0.475 | Death-associated protein kinase 3 inhibitor | 0.338 0.028 DBMET03429 0.338 0.028 DBMET03430 0.344 0.027 DBMET03431 0.402 0.017 DBMET03432 | ||
| 0.422 | 0.003 | 0.422 | MAP kinase kinase 4 inhibitor | 0.266 0.005 DBMET03429 0.266 0.005 DBMET03430 0.386 0.003 DBMET03431 0.342 0.003 DBMET03432 | ||
| 0.406 | 0.013 | 0.406 | CDC-like kinase 2 inhibitor | 0.259 0.043 DBMET03429 0.259 0.043 DBMET03430 0.181 0.077 DBMET03431 0.36 0.019 DBMET03432 | ||
| 0.384 | 0.003 | 0.384 | Janus tyrosine kinase 1 inhibitor | 0.327 0.003 DBMET03429 0.327 0.003 DBMET03430 0.297 0.004 DBMET03431 0.349 0.003 DBMET03432 | ||
| 0.417 | 0.039 | 0.476 | Immunomodulator | 0.329 0.068 DBMET03429 0.329 0.068 DBMET03430 0.476 0.027 DBMET03431 0.443 0.033 DBMET03432 | DBMET03431 | |
| 0.355 | 0.027 | 0.355 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.268 0.052 DBMET03429 0.268 0.052 DBMET03430 0.18 0.088 DBMET03431 0.348 0.029 DBMET03432 | ||
| 0.355 | 0.027 | 0.355 | Clk dual-specificity kinase inhibitor | 0.216 0.07 DBMET03429 0.216 0.07 DBMET03430 0.181 0.091 DBMET03431 0.298 0.039 DBMET03432 | ||
| 0.375 | 0.07 | 0.461 | Toll-Like receptor 7 agonist | 0.417 0.053 DBMET03429 0.417 0.053 DBMET03430 0.224 0.173 DBMET03431 0.461 0.04 DBMET03432 | DBMET03432 | |
| 0.372 | 0.072 | 0.46 | Toll-Like receptor agonist | 0.414 0.055 DBMET03429 0.414 0.055 DBMET03430 0.223 0.176 DBMET03431 0.46 0.041 DBMET03432 | DBMET03432 | |
| 0.3 | 0.005 | 0.3 | Tyk2 inhibitor | 0.193 0.009 DBMET03429 0.193 0.009 DBMET03430 0.164 0.012 DBMET03431 0.241 0.006 DBMET03432 | ||
| 0.31 | 0.029 | 0.31 | CDC-like kinase 4 inhibitor | 0.184 0.076 DBMET03429 0.184 0.076 DBMET03430 0.161 0.092 DBMET03431 0.263 0.042 DBMET03432 | ||
| 0.28 | 0.005 | 0.28 | Raf kinase C inhibitor | 0.276 0.005 DBMET03431 0.136 0.017 DBMET03432 | ||
| 0.282 | 0.011 | 0.411 | MAP kinase kinase inhibitor | 0.228 0.02 DBMET03429 0.228 0.02 DBMET03430 0.165 0.043 DBMET03431 0.411 0.004 DBMET03432 | DBMET03432 | |
| 0.262 | 0.028 | 0.262 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.208 0.044 DBMET03429 0.208 0.044 DBMET03430 0.133 0.075 DBMET03431 0.253 0.03 DBMET03432 | ||
| 0.235 | 0.03 | 0.235 | Antipruritic | 0.192 0.055 DBMET03429 0.192 0.055 DBMET03430 0.146 0.099 DBMET03431 0.205 0.046 DBMET03432 | ||
| 0.24 | 0.036 | 0.24 | Protein kinase C nu inhibitor | 0.142 0.074 DBMET03429 0.142 0.074 DBMET03430 0.111 0.104 DBMET03431 0.216 0.042 DBMET03432 | ||
| 0.273 | 0.085 | 0.273 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.238 0.117 DBMET03429 0.238 0.117 DBMET03430 0.25 0.106 DBMET03432 | ||
| 0.208 | 0.021 | 0.208 | Cyclin-dependent kinase 9 inhibitor | 0.183 0.026 DBMET03429 0.183 0.026 DBMET03430 0.11 0.053 DBMET03431 0.193 0.024 DBMET03432 | ||
| 0.199 | 0.014 | 0.199 | Protein kinase A inhibitor | 0.145 0.026 DBMET03429 0.145 0.026 DBMET03430 0.097 0.047 DBMET03431 0.185 0.016 DBMET03432 | ||
| 0.25 | 0.065 | 0.25 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.233 0.09 DBMET03429 0.233 0.09 DBMET03430 0.232 0.092 DBMET03432 | ||
| 0.233 | 0.047 | 0.233 | LIM domain kinase 1 inhibitor | 0.151 0.097 DBMET03432 | ||
| 0.208 | 0.031 | 0.208 | Cyclin-dependent kinase 7 inhibitor | 0.188 0.039 DBMET03429 0.188 0.039 DBMET03430 0.112 0.091 DBMET03431 0.184 0.04 DBMET03432 | ||
| 0.231 | 0.061 | 0.267 | Platelet aggregation inhibitor | 0.249 0.052 DBMET03429 0.249 0.052 DBMET03430 0.182 0.096 DBMET03431 0.267 0.045 DBMET03432 | DBMET03432 | |
| 0.227 | 0.061 | 0.227 | MAP kinase kinase 3 inhibitor | 0.218 0.078 DBMET03429 0.218 0.078 DBMET03430 0.212 0.091 DBMET03432 | ||
| 0.22 | 0.063 | 0.22 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.202 0.075 DBMET03432 | ||
| 0.203 | 0.06 | 0.203 | Growth factor agonist | 0.176 0.093 DBMET03432 | ||
| 0.176 | 0.034 | 0.183 | Epidermal growth factor receptor kinase inhibitor | 0.144 0.052 DBMET03429 0.144 0.052 DBMET03430 0.183 0.032 DBMET03431 0.181 0.032 DBMET03432 | DBMET03431 | |
| 0.221 | 0.08 | 0.252 | Potassium channel blocker | 0.252 0.066 DBMET03431 0.152 0.133 DBMET03432 | DBMET03431 | |
| 0.216 | 0.083 | 0.216 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.201 0.092 DBMET03432 | ||
| 0.181 | 0.051 | 0.19 | Cyclin-dependent kinase 8 inhibitor | 0.155 0.074 DBMET03429 0.155 0.074 DBMET03430 0.19 0.043 DBMET03432 | DBMET03432 | |
| 0.148 | 0.02 | 0.148 | Rho-associated kinase inhibitor | 0.085 0.043 DBMET03429 0.085 0.043 DBMET03430 0.124 0.026 DBMET03432 | ||
| 0.215 | 0.09 | 0.215 | Dyrk kinase inhibitor | 0.194 0.102 DBMET03432 | ||
| 0.206 | 0.083 | 0.206 | ErbB-1 antagonist | 0.199 0.09 DBMET03429 0.199 0.09 DBMET03430 0.159 0.158 DBMET03431 0.192 0.098 DBMET03432 | ||
| 0.15 | 0.031 | 0.167 | Protein kinase C gamma inhibitor | 0.109 0.064 DBMET03431 0.167 0.023 DBMET03432 | DBMET03432 | |
| 0.132 | 0.018 | 0.132 | Rho-associated kinase I inhibitor | 0.1 0.031 DBMET03432 | ||
| 0.233 | 0.123 | 0.233 | Nootropic | 0.186 0.177 DBMET03431 0.194 0.166 DBMET03432 | ||
| 0.191 | 0.083 | 0.223 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.223 0.062 DBMET03432 | DBMET03432 | |
| 0.15 | 0.05 | 0.15 | Aurora-C kinase inhibitor | 0.149 0.051 DBMET03429 0.149 0.051 DBMET03430 0.135 0.073 DBMET03432 | ||
| 0.105 | 0.012 | 0.105 | Bromodomain-containing protein 4 inhibitor | 0.057 0.036 DBMET03429 0.057 0.036 DBMET03430 0.083 0.018 DBMET03431 0.072 0.023 DBMET03432 | ||
| 0.156 | 0.064 | 0.156 | Protein kinase (CK1) gamma 1 inhibitor | 0.13 0.087 DBMET03432 | ||
| 0.094 | 0.011 | 0.12 | MAP kinase kinase 9 inhibitor | 0.12 0.008 DBMET03432 | DBMET03432 | |
| 0.096 | 0.016 | 0.118 | MAP kinase kinase 7 inhibitor | 0.1 0.013 DBMET03429 0.1 0.013 DBMET03430 0.079 0.049 DBMET03431 0.118 0.005 DBMET03432 | DBMET03432 | |
| 0.1 | 0.023 | 0.102 | I kappa B kinase 1 inhibitor | 0.073 0.044 DBMET03429 0.073 0.044 DBMET03430 0.102 0.021 DBMET03432 | DBMET03432 | |
| 0.145 | 0.068 | 0.145 | Lck kinase inhibitor | 0.132 0.077 DBMET03432 | ||
| 0.078 | 0.004 | 0.079 | AMPA receptor agonist | 0.07 0.004 DBMET03429 0.07 0.004 DBMET03430 0.079 0.004 DBMET03431 0.073 0.004 DBMET03432 | DBMET03431 | |
| 0.109 | 0.038 | 0.109 | Stem cell growth factor agonist | |||
| 0.232 | 0.164 | 0.305 | Immunosuppressant | 0.252 0.146 DBMET03429 0.252 0.146 DBMET03430 0.305 0.112 DBMET03432 | DBMET03432 | |
| 0.111 | 0.043 | 0.111 | Protein kinase C delta inhibitor | 0.081 0.075 DBMET03429 0.081 0.075 DBMET03430 0.105 0.048 DBMET03432 | ||
| 0.076 | 0.009 | 0.076 | Alpha 1b adrenoreceptor agonist | 0.071 0.011 DBMET03429 0.071 0.011 DBMET03430 0.061 0.019 DBMET03431 0.068 0.013 DBMET03432 | ||
| 0.148 | 0.09 | 0.148 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.13 0.105 DBMET03432 | ||
| 0.068 | 0.011 | 0.069 | Glycine transporter 1 inhibitor | 0.069 0.01 DBMET03431 | DBMET03431 | |
| 0.094 | 0.038 | 0.094 | ErbB-2 antagonist | 0.075 0.052 DBMET03429 0.075 0.052 DBMET03430 0.094 0.038 DBMET03432 | ||
| 0.187 | 0.132 | 0.242 | Cardiotonic | 0.242 0.088 DBMET03431 | DBMET03431 | |
| 0.119 | 0.07 | 0.119 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.103 0.083 DBMET03432 | ||
| 0.118 | 0.07 | 0.118 | Abl kinase inhibitor | 0.103 0.083 DBMET03432 | ||
| 0.09 | 0.042 | 0.09 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.072 0.065 DBMET03431 0.075 0.06 DBMET03432 | ||
| 0.113 | 0.066 | 0.113 | CDK3/cyclin E inhibitor | 0.1 0.088 DBMET03431 | ||
| 0.137 | 0.093 | 0.161 | Src kinase inhibitor | 0.161 0.076 DBMET03431 0.126 0.102 DBMET03432 | DBMET03431 | |
| 0.115 | 0.072 | 0.115 | Vascular endothelial growth factor antagonist | 0.11 0.075 DBMET03432 | ||
| 0.093 | 0.05 | 0.093 | Epidermal growth factor antagonist | 0.075 0.073 DBMET03429 0.075 0.073 DBMET03430 0.092 0.051 DBMET03432 | ||
| 0.072 | 0.03 | 0.072 | CDK9/cyclin T1 inhibitor | 0.052 0.049 DBMET03429 0.052 0.049 DBMET03430 0.062 0.038 DBMET03432 | ||
| 0.047 | 0.006 | 0.047 | LIM domain kinase 2 inhibitor | 0.039 0.01 DBMET03429 0.039 0.01 DBMET03430 0.034 0.016 DBMET03431 0.039 0.01 DBMET03432 | ||
| 0.075 | 0.034 | 0.075 | MAP kinase kinase 10 inhibitor | |||
| 0.066 | 0.03 | 0.066 | Alpha 1 adrenoreceptor agonist | |||
| 0.041 | 0.007 | 0.041 | Alpha 1a adrenoreceptor agonist | 0.023 0.015 DBMET03429 0.023 0.015 DBMET03430 0.023 0.015 DBMET03431 0.027 0.012 DBMET03432 | ||
| 0.157 | 0.123 | 0.157 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.156 0.125 DBMET03431 0.155 0.125 DBMET03432 | ||
| 0.066 | 0.032 | 0.066 | Phosphatidylinositol 3-kinase delta inhibitor | 0.058 0.04 DBMET03432 | ||
| 0.097 | 0.064 | 0.116 | MAP kinase 8 inhibitor | 0.116 0.046 DBMET03432 | DBMET03432 | |
| 0.074 | 0.042 | 0.074 | Alpha adrenoreceptor agonist | |||
| 0.079 | 0.048 | 0.079 | Protein kinase B gamma inhibitor | |||
| 0.102 | 0.075 | 0.102 | Polo-like kinase-4 inhibitor | |||
| 0.086 | 0.061 | 0.093 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.086 0.062 DBMET03429 0.086 0.062 DBMET03430 0.093 0.053 DBMET03432 | DBMET03432 | |
| 0.035 | 0.011 | 0.041 | Purinergic P2T antagonist | 0.041 0.01 DBMET03431 | DBMET03431 | |
| 0.146 | 0.125 | 0.158 | MAP kinase kinase 2 inhibitor | 0.158 0.114 DBMET03432 | DBMET03432 | |
| 0.055 | 0.033 | 0.06 | Neuropeptide Y5 antagonist | 0.06 0.03 DBMET03431 | DBMET03431 | |
| 0.098 | 0.077 | 0.119 | Cyclin-dependent kinase 5 inhibitor | 0.119 0.059 DBMET03431 0.088 0.087 DBMET03432 | DBMET03431 | |
| 0.068 | 0.048 | 0.128 | MAP kinase kinase 8 inhibitor | 0.128 0.013 DBMET03432 | DBMET03432 | |
| 0.268 | 0.247 | 0.304 | Antiinflammatory | 0.304 0.212 DBMET03432 | DBMET03432 | |
| 0.095 | 0.075 | 0.095 | Vascular endothelial growth factor 2 antagonist | 0.091 0.079 DBMET03432 | ||
| 0.06 | 0.042 | 0.06 | Alpha 2 adrenoreceptor agonist | |||
| 0.119 | 0.102 | 0.119 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | |||
| 0.113 | 0.097 | 0.113 | Protein kinase (CK1) gamma inhibitor | |||
| 0.066 | 0.052 | 0.066 | Protein kinase B alpha inhibitor | |||
| 0.093 | 0.079 | 0.093 | Hedgehog signaling inhibitor | |||
| 0.036 | 0.026 | 0.04 | Antibiotic Aminoglycoside-like | 0.04 0.021 DBMET03429 0.04 0.021 DBMET03430 0.037 0.024 DBMET03431 0.037 0.024 DBMET03432 | DBMET03430 | |
| 0.075 | 0.068 | 0.075 | ErbB-3 antagonist | |||
| 0.036 | 0.03 | 0.038 | Glucose-6-phosphate dehydrogenase inhibitor | 0.038 0.024 DBMET03431 0.036 0.03 DBMET03432 | DBMET03431 | |
| 0.265 | 0.264 | 0.265 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.096 | 0.095 | 0.096 | Activin receptor-like kinase 4 inhibitor | |||
| 0.184 | 0.189 | 0.205 | Angiogenesis inhibitor | 0.205 0.164 DBMET03432 | DBMET03432 | |
| 0.077 | 0.084 | 0.088 | Aminoacyl-tRNA synthetase inhibitor | 0.088 0.062 DBMET03432 | DBMET03432 | |
| 0.041 | 0.05 | 0.044 | Phosphatidylinositol 3-kinase beta inhibitor | 0.044 0.042 DBMET03432 | DBMET03432 | |
| 0.075 | 0.091 | 0.123 | MAP kinase 9 inhibitor | 0.123 0.048 DBMET03432 | DBMET03432 | |
| 0.062 | 0.079 | 0.149 | Focal adhesion kinase 1 inhibitor | 0.149 0.01 DBMET03431 | DBMET03431 | |
| 0.028 | 0.047 | 0.054 | Secretase gamma inhibitor | 0.054 0.022 DBMET03431 | DBMET03431 | |
| 0.073 | 0.093 | 0.086 | Cyclin-dependent kinase 1 inhibitor | 0.086 0.078 DBMET03431 | DBMET03431 | |
| 0.156 | 0.183 | 0.179 | RNA-directed DNA polymerase inhibitor | 0.179 0.135 DBMET03429 0.179 0.135 DBMET03430 | DBMET03430 | |
| 0.106 | 0.144 | 0.147 | MAP3K9 inhibitor | 0.147 0.064 DBMET03432 | DBMET03432 | |
| 0.122 | 0.19 | 0.139 | Cyclin-dependent kinase 3 inhibitor | 0.139 0.124 DBMET03429 0.139 0.124 DBMET03430 | DBMET03430 | |
| 0.113 | 0.184 | 0.252 | Aldehyde oxidase inhibitor | 0.252 0.081 DBMET03429 0.252 0.081 DBMET03430 0.154 0.136 DBMET03432 | DBMET03430 | |
| 0.041 | 0.114 | 0.069 | CDK2/cyclin E2 inhibitor | 0.069 0.049 DBMET03429 0.069 0.049 DBMET03430 | DBMET03430 | |
| 0.058 | 0.153 | 0.117 | c-Src kinase inhibitor | 0.117 0.077 DBMET03431 | DBMET03431 | |
| 0.087 | 0.187 | 0.125 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.125 0.12 DBMET03432 | DBMET03432 | |
| 0.086 | 0.254 | 0.167 | Platelet antagonist | 0.167 0.128 DBMET03431 | DBMET03431 | |
| 0.021 | 0.192 | 0.057 | Cyclin B1 inhibitor | 0.057 0.048 DBMET03431 | DBMET03431 | |
| 0.015 | 0.205 | 0.05 | Cyclin B2 inhibitor | 0.05 0.048 DBMET03431 | DBMET03431 | |
| 0.02 | 0.24 | 0.067 | Phosphodiesterase 5A inhibitor | 0.067 0.054 DBMET03431 | DBMET03431 | |
| 0.019 | 0.243 | 0.067 | Phosphodiesterase V inhibitor | 0.067 0.055 DBMET03431 | DBMET03431 | |
| 0.077 | 0.476 | 0.22 | Sodium/bile acid cotransporter inhibitor | 0.22 0.162 DBMET03432 | DBMET03432 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |